These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36109154)

  • 21. Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.
    Kuitwaard K; van Doorn PA; Bengrine T; van Rijs W; Baas F; Nagelkerke SQ; Kuijpers TW; Fokkink WR; Bunschoten C; Broers MC; Willemsen SP; Jacobs BC; Huizinga R
    Eur J Neurol; 2021 May; 28(5):1677-1683. PubMed ID: 33460483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CIDP Refractory to Three Types of Mainstay Treatments: Differential Diagnosis and Treatment Strategies].
    Iijima M
    Brain Nerve; 2022 May; 74(5):517-524. PubMed ID: 35589641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
    Rodríguez Y; Vatti N; Ramírez-Santana C; Chang C; Mancera-Páez O; Gershwin ME; Anaya JM
    J Autoimmun; 2019 Aug; 102():8-37. PubMed ID: 31072742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy.
    Bedlack RS; Vu T; Hammans S; Sparr SA; Myers B; Morgenlander J; Hirano M
    Muscle Nerve; 2004 Mar; 29(3):364-8. PubMed ID: 14981734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin: a first-line treatment in CIDP?
    Vermeulen M
    Lancet Neurol; 2008 Feb; 7(2):115-6. PubMed ID: 18178526
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Shije J; Brannagan TH
    Semin Neurol; 2019 Oct; 39(5):596-607. PubMed ID: 31639843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatments for CIDP.
    Ropper AH
    Neurology; 2003 Apr; 60(8 Suppl 3):S16-22. PubMed ID: 12707418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.
    Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S
    Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin?
    Sladky JT
    Muscle Nerve; 2008 Dec; 38(6):1638-43. PubMed ID: 19016535
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
    Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
    J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
    van Schaik IN; Winer JB; de Haan R; Vermeulen M
    Lancet Neurol; 2002 Dec; 1(8):491-8. PubMed ID: 12849334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
    Van den Bergh PYK; van Doorn PA; Hadden RDM; Avau B; Vankrunkelsven P; Allen JA; Attarian S; Blomkwist-Markens PH; Cornblath DR; Eftimov F; Goedee HS; Harbo T; Kuwabara S; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Sommer C; Topaloglu HA
    J Peripher Nerv Syst; 2021 Sep; 26(3):242-268. PubMed ID: 34085743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Hughes R
    J Clin Immunol; 2010 May; 30 Suppl 1():S70-3. PubMed ID: 20393791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammatory demyelinating polyneuropathy.
    Köller H; Kieseier BC; Jander S; Hartung HP
    N Engl J Med; 2005 Mar; 352(13):1343-56. PubMed ID: 15800230
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic inflammatory demyelinating polyneuropathy.
    Gorson KC; Katz J
    Neurol Clin; 2013 May; 31(2):511-32. PubMed ID: 23642722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic Strategies for Inflammatory Neuropathy].
    Nishihara H; Kanda T
    Brain Nerve; 2023 May; 75(5):533-538. PubMed ID: 37194526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
    Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
    Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.